Area 57 initiative to propel Malaysia in drone race thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.
KUALA LUMPUR, Sept 16 ― A locally produced cholera vaccine will begin its first clinical trials by the end of this year, Ministry of Science, Technology and Innovation (Mosti) said today. Minister Datuk Seri Dr Adham Baba said Universiti Sains Malaysia (USM) was working with the Asian Institute.
KUALA LUMPUR, Sept 16 Science, Technology and Innovation Minister Datuk Seri Dr Adham Baba launched a drone development zone dubbed “Area 57” at Technology Park Malaysia, here today. He said the location was equipped with a 100m runway, 300-sq-m drone net area, drone testing mock-up site,.
Acute care nurses | Daily Express Online - Sabah s Leading News Portal dailyexpress.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexpress.com.my Daily Mail and Mail on Sunday newspapers.
FILE PHOTO: Vials of a COVID-19 vaccine candidate, a recombinant adenovirus vaccine named Ad5-nCoV, co-developed by Chinese biopharmaceutical firm CanSino Biologics Inc and a team led by Chinese military infectious disease expert, are pictured in Wuhan, Hubei province, China March 24, 2020. China Daily via REUTERS
KUALA LUMPUR (Bernama): Solution Group Bhd’s (SGB) wholly-owned subsidiary, Solution Biologics Sdn Bhd (SolBio) has signed a finished product and a bulk product agreement today with CanSino Biologics Inc for the supply of the Recombinant Ad5-nCoV vaccine for use against Covid-19.
In a statement, the group said the finished product agreement allows SolBio to purchase and CanSino to supply the finish product vaccine for emergency use in Malaysia.